{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:46:15Z","timestamp":1793490375425,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jacc.2020.11.002","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T15:55:15Z","timestamp":1610553315000},"page":"205-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Cardiovascular Complications of Opioid\u00a0Use"],"prefix":"10.1016","volume":"77","author":[{"given":"Mori J.","family":"Krantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.P.","family":"Haigney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.11.002_bib1","first-page":"171","article-title":"History of opium poppy and morphine","volume":"33","author":"Norn","year":"2005","journal-title":"Dan Medicinhist Arbog"},{"key":"10.1016\/j.jacc.2020.11.002_bib2","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.12659\/MSM.905167","article-title":"Reciprocal evolution of opiate science from medical and cultural perspectives","volume":"23","author":"Stephano","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jacc.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1073\/pnas.90.12.5391","article-title":"A\u00a0brief history of opiates, opioid peptides, and opioid receptors","volume":"90","author":"Brownstein","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2020.11.002_bib4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.181.4101.716","article-title":"The dynamics of a heroin addiction epidemic","volume":"181","author":"DuPont","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jacc.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2019.12.010","article-title":"Call to action opioid crisis. Impacting more than just patients","volume":"75","author":"Kovacs","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aer115","article-title":"Opioid receptor subtypes: fact or artifact?","volume":"107","author":"Dietis","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacc.2020.11.002_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/138945012799201612","article-title":"Current research on opioid receptor function","volume":"13","author":"Feng","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jacc.2020.11.002_bib10","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0735-1097(00)01011-1","article-title":"Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle","volume":"36","author":"Bell","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1210\/jc.2004-2554","article-title":"Acute pressor and hormonal effects of beta endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism","volume":"90","author":"Cozzolino","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2020.11.002_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2020.11.002_bib13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","article-title":"Coronary artery disease and opioid use","volume":"93","author":"Marmor","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jacc.2005.12.060","article-title":"Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction","volume":"47","author":"Patrizi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/joim.12035","article-title":"Opioid use for noncancer pain and risk of myocardial infarction amongst adults","volume":"273","author":"Li","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib16","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/ijerph16142564","article-title":"Exploring unconventional risk-factors for cardiovascular diseases: has opioid therapy been overlooked?","volume":"16","author":"Ogungbe","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2020.11.002_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/pds.2131","article-title":"Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort","volume":"20","author":"Carman","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2020.11.002_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0002-9343(71)90298-1","article-title":"A\u00a0clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema","volume":"51","author":"Duberstein","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib19","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.amjcard.2019.07.068","article-title":"Frequency of cardiovascular events and in-hospital mortality with opioid overdose hospitalizations","volume":"124","author":"Doshi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib20","first-page":"444","article-title":"Prescription opioid use and risk of coronary heart disease, stroke, and cardiovascular death among adults from a prospective cohort (REGARDS Study)","volume":"17","author":"Khodneva","year":"2016","journal-title":"Pain Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/STROKEAHA.118.024436","article-title":"National trends in hospitalizations for stroke associated with infective endocarditis and opioid use between 1993 and 2015","volume":"50","author":"Omran","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","article-title":"Clinical outcomes of infective endocarditis in injection drug users","volume":"73","author":"Rudasill","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib23","first-page":"84","article-title":"Heart failure due to \u2018stress cardiomyopathy\u2019: a severe manifestation of the opioid withdrawal syndrome","volume":"2","author":"Spadotto","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jacc.2020.11.002_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40800-018-0088-x","article-title":"Naloxone-induced non-cardiogenic pulmonary edema: a case report.","volume":"5","author":"Jiwa","year":"2018","journal-title":"Drug Saf Case Rep"},{"key":"10.1016\/j.jacc.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0735-1097(99)00095-9","article-title":"Effects of naloxone on myocardial ischemic preconditioning in humans","volume":"33","author":"Tomai","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijcard.2016.03.079","article-title":"Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: data from international safety surveillance","volume":"212","author":"Sandhu","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib29","first-page":"1","article-title":"Drug poisoning deaths in the United States, 1980-2008","author":"Warner","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jacc.2020.11.002_bib30","first-page":"A12773","article-title":"Association of opioid use with atrial fibrillation in a post-9\/11 veteran population (abstr).","volume":"138","author":"Stock","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.11.002_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","article-title":"Influence of opioid agonists on cardiac human ether-a-go-go related gene currents","volume":"303","author":"Katchman","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2020.11.002_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2008.03327.x","article-title":"Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in\u00a0vitro","volume":"67","author":"Fanoe","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.amjcard.2004.11.055","article-title":"Impact of methadone treatment on cardiac repolarization and conduction in opioid users","volume":"95","author":"Martell","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J069v20n04_02","article-title":"Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM)","volume":"20","author":"Deamer","year":"2001","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.jacc.2020.11.002_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2007.10.009","article-title":"A\u00a0community-based evaluation of sudden death associated with therapeutic levels of methadone","volume":"121","author":"Chugh","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax9140","article-title":"Current status of opioid addiction treatment and related preclinical research","volume":"5","author":"Kreek","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacc.2020.11.002_bib38","first-page":"493","article-title":"Vital signs: risk for overdose from methadone used for pain relief\u2014United States, 1999-2010","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2020.11.002_bib39","first-page":"706","article-title":"Electrocardiographic changes in heroin, methadone and multiple drug abuse: a postulated mechanism of sudden death in narcotic addicts","volume":"1","author":"Stimmel","year":"1973","journal-title":"Proc Natl Conf Methadone Treat"},{"key":"10.1016\/j.jacc.2020.11.002_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2020.11.002_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.amjcard.2007.07.068","article-title":"Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome","volume":"101","author":"Patel","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-158-10-201305210-00008","article-title":"Trends in reporting of methadone-associated cardiac arrhythmia events, 1997-2011","volume":"158","author":"Kao","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib43","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/add.13013","article-title":"Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration","volume":"110","author":"Kao","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jacc.2020.11.002_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1360-0443.2006.01668.x","article-title":"Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study","volume":"102","author":"Peles","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jacc.2020.11.002_bib45","series-title":"Guidance for industry: E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs","year":"2005"},{"key":"10.1016\/j.jacc.2020.11.002_bib46","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib47","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","article-title":"QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","volume":"167","author":"Wedam","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib48","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjp.0705336","article-title":"Drug binding to HERG channels: evidence for a \u2018non-aromatic\u2019 binding site for fluvoxamine","volume":"139","author":"Mitcheson","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archinternmed.2010.26","article-title":"Substitution of (R,S)-methadone by (R)-methadone: impact on QTc interval","volume":"170","author":"Ansermot","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib50","author":"Solhjoo"},{"key":"10.1016\/j.jacc.2020.11.002_bib51","article-title":"Electrocardiographic changes in children with acute opioid poisoning: a cross-sectional study","author":"Riasi","year":"2019","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jacc.2020.11.002_bib52","doi-asserted-by":"crossref","first-page":"524764","DOI":"10.4061\/2010\/524764","article-title":"Torsade de Pointes due to methadone use in a patient with HIV and hepatitis C coinfection","volume":"2010","author":"John","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jacc.2020.11.002_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10550880802122596","article-title":"Electrocardiogram characteristics of methadone and buprenorphine maintained subjects","volume":"27","author":"Athanasos","year":"2008","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.jacc.2020.11.002_bib54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.hrthm.2008.11.024","article-title":"IK1 modulates the U-wave: insights in a 100-year-old enigma","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.11.002_bib55","doi-asserted-by":"crossref","first-page":"A17074","DOI":"10.1161\/circ.142.suppl_3.17074","article-title":"Methadone potently blocks cardiac IK1\u00a0leading to membrane instability (abstr)","volume":"142","author":"Klein","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.11.002_bib56","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.hrthm.2017.04.001","article-title":"Role of inward rectifier current (IK1) suppression on terminal action potential repolarization in the failing heart","volume":"14","author":"Klein","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.11.002_bib57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bph.12465","article-title":"The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na+ channel, Na(v)1.5","volume":"717","author":"Schulze","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib58","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-3623(79)90089-2","article-title":"Anti-cholinesterase activity of 1-alpha-acetylmethadol: relationship to bradycardia","volume":"10","author":"Eikenburg","year":"1979","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib60","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0272-0590(83)80101-8","article-title":"Calcium channel blockade by certain opioids","volume":"3","author":"Seyler","year":"1983","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.jacc.2020.11.002_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-3565(25)32287-1","article-title":"Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM)","volume":"215","author":"Rendig","year":"1980","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2020.11.002_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.PCC.0000192337.00842.1E","article-title":"Bradycardia during methadone therapy in an infant","volume":"7","author":"Wheeler","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib63","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1592\/phco.22.13.1196.33511","article-title":"Bradycardia associated with intravenous methadone administered for sedation in a patient with acute respiratory distress syndrome","volume":"22","author":"Karir","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2020.11.002_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1300\/J069v24n01_05","article-title":"Cocaine-related torsade de pointes in a methadone maintenance patient","volume":"24","author":"Krantz","year":"2005","journal-title":"J\u00a0Addict Dis"},{"key":"10.1016\/j.jacc.2020.11.002_bib65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3565(24)29321-6","article-title":"Effects of cocaine and its major metabolites on the HERG-encoded potassium channel","volume":"299","author":"Ferreira","year":"2001","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2020.11.002_bib66","unstructured":"Prescription Drug Information: Dolophine. Available from: https:\/\/rxdruglabels.com\/lib\/rx\/rx-meds\/dolophine\/. Accessed November 16, 2020."},{"key":"10.1016\/j.jacc.2020.11.002_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","article-title":"QTc interval screening in methadone treatment","volume":"150","author":"Krantz","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib68","first-page":"CD008939","article-title":"QTc interval screening for cardiac risk in methadone treatment of opioid dependence","volume":"6","author":"Pani","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2020.11.002_bib69","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.amjcard.2013.05.037","article-title":"QTc interval screening in an opioid treatment program","volume":"112","author":"Katz","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib71","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1592\/phco.25.4.611.61020","article-title":"Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes","volume":"25","author":"Krantz","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2020.11.002_bib72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1345\/aph.1G524","article-title":"Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients","volume":"40","author":"Baker","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2020.11.002_bib73","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cpt.1406","article-title":"Evaluation of the effects of a monthly buprenorphine depot subcutaneous injection on QT interval during treatment for opioid use disorder","volume":"106","author":"Schmith","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2020.11.002_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1081\/CLT-66069","article-title":"ECG abnormalities in co-proxamol (paracetamol\/dextropropoxyphene) poisoning","volume":"43","author":"Afshari","year":"2005","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jacc.2020.11.002_bib76","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1399-6576.1984.tb02141.x","article-title":"Acute propoxyphene self-poisoning in 222 consecutive patients","volume":"28","author":"Sloth Madsen","year":"1984","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jacc.2020.11.002_bib77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(99)00258-8","article-title":"Norpropoxyphene-induced cardiotoxicity is associated with changes in ion-selectivity and gating of HERG currents","volume":"44","author":"Ulens","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2020.11.002_bib78","series-title":"Darvon, Darvon-N, Darvocet-N-50\/100. Submission number 039\/040","article-title":"Interdisciplinary review team for QT studies consultation: multiple ascending dose (MAD) study review IND. 70462.","author":"Balakrishnan","year":"2010"},{"key":"10.1016\/j.jacc.2020.11.002_bib79","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.hrthm.2011.07.015","article-title":"Propoxyphene-induced torsades de pointes","volume":"8","author":"Adler","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.11.002_bib80","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.3411","article-title":"Propoxyphene and the risk of out-of-hospital death","volume":"22","author":"Ray","year":"2013","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.jacc.2020.11.002_bib81","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/15563650903218757","article-title":"European Medicines Evaluation Agency bans dextropropoxyphene: a landmark decision for clinical toxicology?","volume":"47","author":"Bateman","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jacc.2020.11.002_bib83","first-page":"e38","article-title":"Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines","volume":"24","author":"Baranchuk","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/qjmed\/hcs176","article-title":"Oxycodone overdose causes naloxone responsive coma and QT prolongation","volume":"106","author":"Berling","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.jacc.2020.11.002_bib85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2012.11.003","article-title":"\u201cI just wanted to tell you that loperamide WILL WORK\u201d: a web-based study of extra-medical use of loperamide","volume":"130","author":"Daniulaityte","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jacc.2020.11.002_bib86","first-page":"1897","article-title":"Torsade de pointes associated with high-dose loperamide ingestion","volume":"6","author":"Marzec","year":"2015","journal-title":"J\u00a0Innov Card Rhythm Manage"},{"key":"10.1016\/j.jacc.2020.11.002_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00210-016-1286-7","article-title":"Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic","volume":"389","author":"Kang","year":"2016","journal-title":"Arch Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib88","first-page":"784","article-title":"Potent inhibition of hERG channels by the over-the-counter antidiarrheal agent loperamide","volume":"2","author":"Klein","year":"2016","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2020.11.002_bib89","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.japh.2016.11.011","article-title":"Adverse event detection using the FDA post-marketing drug safety surveillance system: cardiotoxicity associated with loperamide abuse and misuse","volume":"57","author":"Swank","year":"2017","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.jacc.2020.11.002_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204443","article-title":"Is there such a thing as a \u2018lope\u2019 dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports","volume":"13","author":"Schifano","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2020.11.002_bib91","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)05201-2","article-title":"Actions and addiction liabilities of Dromoran derivatives in man","volume":"107","author":"Isbell","year":"1953","journal-title":"J\u00a0Pharmacol Ther"},{"key":"10.1016\/j.jacc.2020.11.002_bib92","first-page":"169","article-title":"A\u00a0possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: comparing 1998 to 1999","volume":"44","author":"Baker","year":"2002","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.jacc.2020.11.002_bib93","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijcard.2010.09.024","article-title":"QTc prolongation due to dextromethorphan","volume":"148","author":"Kaplan","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib94","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0b013e31818eec8d","article-title":"Effects of common antitussive drugs on the hERG potassium channel current","volume":"52","author":"Deisemann","year":"2008","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.002_bib96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCGENETICS.109.898569","article-title":"A\u00a0common single nucleotide polymorphism can exacerbate long QT type 2 syndrome leading to sudden infant death","volume":"3","author":"Nof","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2020.11.002_bib97","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1378\/chest.128.3.1348","article-title":"Central sleep apnea in stable methadone maintenance treatment patients","volume":"128","author":"Wang","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2020.11.002_bib98","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/sleep\/14.4.346","article-title":"Changes in the QT interval during obstructive sleep apnea","volume":"14","author":"Gillis","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.jacc.2020.11.002_bib99","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2009.06.038","article-title":"Triggering of nocturnal arrhythmias by sleep-disordered breathing events","volume":"54","author":"Monahan","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.11.002_bib101","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.hrthm.2011.03.055","article-title":"QT variability index on 24-hour Holter independently predicts mortality in patients with heart failure","volume":"8","author":"Dobson","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2020.11.002_bib102","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","article-title":"Methadone deaths: risk factors in pain and addicted populations","volume":"25","author":"Modesto-Lowe","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2020.11.002_bib103","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0038-1666862","article-title":"Fentanyl delays the platelet inhibition effects of oral ticagrelor: full report of the PACIFY randomized clinical trial","volume":"118","author":"Ibrahim","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2020.11.002_bib104","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0735-1097(00)01011-1","article-title":"Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle","volume":"36","author":"Bell","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib105","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamacardio.2020.1445","article-title":"Development of persistent opioid use after cardiac surgery","volume":"5","author":"Brown","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.11.002_bib106","first-page":"321","article-title":"American Pain Society and College on Problems of Drug Dependence. Methadone safety guidelines. Methadone safety: a clinical practice guideline","volume":"15","year":"2014","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jacc.2020.11.002_bib107","unstructured":"Substance Abuse and Mental Health Data Archive. Drug Abuse Warning Network (DAWN). Available at: https:\/\/www.datafiles.samhsa.gov\/study-series\/drug-abuse-warning-network-dawn-nid13516. Accessed November 16, 2020."}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720377305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720377305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:38:05Z","timestamp":1760017085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720377305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0735109720377305"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.002","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Complications of Opioid\u00a0Use","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}